Login Logout

free countersfree counters

Asiento asignado por el Registro Nacional de Asociaciones Español: Grupo 1º, Sección 1ª, Numero 600121 - NIF: G76556646 ...

Estudios e Investigaciones - Documentacion

  1. A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and Its Role in the Model Psychosis Dr Tods.pdf
  2. A Comparative Study of Andongpoh and Musam Korean Hemp. The Production of Two Distinct Qualities of Hemp Cloth.Min Sun Hwang.2008.pdf
  3. A Critical Role for the Cannabinoid CB1 Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking.pdf
  4. A Decrease in Anandamide Signaling Contributes to the Maintenance of Cutaneous Mechanical Hyperalgesia.pdf
  6. A Molecular Basis of Analgesic Tolerance to Cannabinoids.pdf
  7. A Numerical Taxonomic Analysis of Cannabis with Special Reference to Species Delimitation Small1976.pdf
  8. A Peripheral Mechanism For CB1 Cannabinoid Receptor-Dependent Modulation of Feeding.pdf
  9. A Population-Based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma.pdf
  10. A Smoking Gun-The Impact of Cannabis Smoking on Respiration Health BLF 2002.pdf
  11. A Within-Subject Comparison of Withdrawal Symptoms During Abstinence From Cannabis Tobacco and Both Substances.pdf
  12. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiformepdf.pdf
  13. A retrospective analysis of cannabis use in a cohort.pdf
  14. Aberrant Frontal and Temporal Complex Network Structure in Schizophrenia.pdf
  15. Absence of Tetra-9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice.pdf
  16. Acomplia rimonabant WC500021287.pdf
  17. Acute Cannabinoids Impair Working Memory through Astroglial CB1 Receptor Modulation of Hippocampal LTD 2012.pdf
  18. Acute Myocardial Infarction in a Young Man-Fatal Blow of the Marijuana-A Case Report.pdf
  19. Acute cannabis consumption and motor vehicle collision risk-systematic review of observational studies and meta analysis.09February2012.pdf
  20. Advanced Mathematical Model To Describe The Production Of Biodiesel Process.pdf
  21. Adverse effects of medical cannabinoids--A systematic review.pdf
  22. Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults.pdf
  23. Agonist-Induced Internalization and Trafficking of Cannabinoid CB1 Receptors in Hippocampal Neurons.pdf
  24. Alcool tabac cannabis et autres drogues illicites parmi les élèves de collège et de lycée.ESPAD.1999.France.pdf
  25. Alteration of Theta Timescale Dynamics of Hippocampal Place Cells by a Cannabinoid Is Associated with Memory Impairment.pdf
  26. Alterations of endocannabinoid signaling synaptic plasticity learning and memory in monoacylglycerol lipase knockout mice.pdf
  27. Amygdala activity contributes to the dissociative effect of cannabis on pain perception.pdf
  28. An Initial Trial of a Computerized Behavioral Intervention for Cannabis Use Disorder.pdf
  29. Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition.pdf
  30. Analyse des Fasergehaltes von verschiedenen Hanfformenpdf.pdf
  31. Anterior Mediastinal Mass in a Young Marijuana Smoker-A Rare Case of Small-Cell Lung Cancer.pdf
  32. Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.pdf
  33. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.pdf
  34. Antidepressant-like effects of cannabidiol in mice possible involvement of 5-HT1A receptors.pdf
  35. Antimicrobial Activity of Cannabis sativa L. 15.december.2012..pdf
  36. Antimicrobial compounds as side products from the agricultural processing industry.pdf
  37. Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma-J Pharmacol Exp Ther-2006-Ligresti.pdf
  38. Antitumor effects of cannabidiol a nonpsychoactive cannabinoid on human glioma cell lines-J Pharmacol Exp Ther-2004-Massi.pdf
  39. Antitumorigenic Effects of Cannabinoids beyond Apoptosis.pdf
  40. Aprovechamiento integral del Cannabis sativa como material de refuerzo-carga del polipropileno.pdf
  41. Aproximaciones boitecnologicas tendentes a la mejora del cannabis.Imane Wahby2007.pdf
  42. Association of Cannabis Use during Adolescence Prefrontal CB1 Receptor Signaling and Schizophrenia.pdf
  43. Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands.pdf
  44. Beta-caryophyllene is a dietary cannabinoid.pdf
  45. Bilateral testicular self-castration due to cannabis abuse a case report.pdf
  46. Biology of Marijuana - From gene to behavior.pdf
  47. Biomarkers for the effects of cannabis and THC in healthy volunteers.pdf
  48. Biomarkers of exposure and effect for environmental carcinogens and their applicability to human molecular epidemiological studies.pdf
  49. Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus.pdf
  51. CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents.pdf
  52. Cannabaceae.pdf
  53. Cannabidiol-Induced Apoptosis in Human Leukemia Cells- A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression--2006-McKallip.pdf
  54. Cannabidiol-a nonpsychotropic component of cannabis inhibits cue-induced heroin-seeking and normalizes discrete mesolimbic neuronal disturbances.pdf
  55. Cannabidiol Attenuates the Appetitive Effects of D9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis.pdf
  56. Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice.pdf
  57. Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels.pdf
  58. Cannabidiol a Nonpsychotropic Component of Cannabis,.pdf
  59. Cannabidiol and -Delta9-tetrahydrocannabinol are neuroprotective antioxidants.pdf
  60. Cannabidiol and .- Delta9-tetrahydrocannabinol are neuroprotective antioxidants.pdf
  61. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo- Relevance to Alzheimer Disease.pdf
  62. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells .pdf
  63. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.pdf
  64. Cannabidiol extracted from Cannabis sativa selectively inhibits inflammatory hypermotility in mice.pdf
  65. Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1 beta and iNOS expression.pdf
  66. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.pdf
  67. Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism.pdf
  68. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL-6 mice.pdf
  69. Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.pdf
  70. Cannabinoid Concentrations in Hair from Documented Cannabis Users.pdf
  71. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.pdf
  72. Cannabinoid Action Depends on Phosphorylation of Dopamine and cAMP-Regulated Phosphoprotein.pdf
  73. Cannabinoid Addiction Behavioral Models and Neural Correlates.pdf
  74. Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex Comparison of Schizophrenia and Major Depressive Disorder.pdf
  75. Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis.pdf
  76. Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products.pdf
  77. Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans.pdf
  78. Cannabinoid Receptor Activation in the Basolateral Amygdala Blocks the Effects of Stress.pdf
  79. Cannabinoid Transmission in the Basolateral Amygdala Modulates Fear Memory Formation via Functional Inputs to the Prelimbic Cortex.pdf
  80. Cannabinoid Typ 1-Rezeptorblockade vermittelt depotspezifische Effekte auf Differenzierung Inflammation und oxidativen Metabolismus in subkutanen und viszeralen Adipozyten.pdf
  81. Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice.pdf
  82. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells -Sublemental figure.pdf
  83. Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells.pdf
  84. Cannabinoid control of neuroinflammation related to multiple sclerosis.pdf
  85. Cannabinoid hyperemesis.pdf
  86. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.pdf
  87. Cannabinoide und das Endocannabinoidsystem Franjo Grotenhermen.pdf
  88. Cannabinoidrezeptor CB1 und Endothelin B Rezeptor.pdf
  89. Cannabinoids Potentiate Emotional Learning Plasticity in Neurons.pdf
  90. Cannabinoids.Handbook of Experimental Pharmacology.pdf
  91. Cannabinoids Decrease Corticostriatal Synaptic Transmission via an Effect on Glutamate Uptake.pdf
  92. Cannabinoids Delta-9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon- beta-STAT proinflammatory pathways in BV2 microglial cells.pdf
  93. Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex.pdf
  94. Cannabinoids Endocannabinoids and Related Analogs in Inflammation.pdf
  95. Cannabinoids Enhance NMDA-Elicited Ca2+ Signals in Cerebellar Granule Neurons in Culture.pdf
  96. Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex.pdf
  97. Cannabinoids Reveal the Necessity of Hippocampal Neural Encoding for Short-Term Memory in Rats.pdf
  98. Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures.pdf
  99. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.pdf
  100. Cannabinoids as a potential new drug therapy for the treatment of gliomas.pdf
  101. Cannabinoids in the management of difficult to treat pain.pdf
  102. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.pdf
  103. Cannabinoids inhibit calcium uptake by brain synaptosomes.pdf
  104. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.pdf
  105. Cannabis- extracting the medicine.pdf
  106. Cannabis-sativa-l-marihuana-vi-variations-in-marihuana-preparations-and-usage-chemical-and-pharmacological-consequences.pdf
  107. Cannabis Profiling Based on Its Elemental.pdf
  108. Cannabis Sativa L. e Substancias Canabinoides em Medicina-ESTUDIO EN PORTUGUES.pdf
  109. Cannabis Use and Cognition in Schizophrenia.pdf
  110. Cannabis Use in Patients with Fibromyalgia Effect on Symptoms Relief and Health-Related Quality of Life.pdf
  111. Cannabis als Medizin–moeglichkeitenN und Grenzen.pdf
  112. Cannabis and First-Episode Psychosis Different Long-term Outcomes Depending on Continued or Discontinued Use.pdf
  113. Cannabis and memory loss.pdf
  114. Cannabis and psychosis-schizophrenia human studies.pdf
  115. Cannabis and sport.pdf
  116. Cannabis and the lung.pdf
  117. Cannabis and tobacco smoke are not equally carcinogenic.pdf
  118. Cannabis as a substitute for alcohol and other drugs.pdf
  119. Cannabis bezogende stoerungen awmf ll 2004.pdf
  120. Cannabis como recurso fitogenetico.pdf
  121. Cannabis in der westlichen Medizin Franjo Grotenhermer.2001.pdf
  122. Cannabis origin determination using plant and soil elemental profiles-libro-2000.pdf
  123. Cannabis rigin etermination using plant and soil elemental profiles-2000.pdf
  124. Cannabis tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa.pdf
  125. Cannabis use and cancer of the head and neck Case-control study.pdf
  126. Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients a prospective longitudinal study.pdf
  127. Cannabis use and mental health in young people.ppr1195-1.pdf
  128. Cannabis use in adolescence and risk for adult psychosis.ppr1212-1.pdf
  129. Cannabis users differ from non-users on measures of personality and schizotypy.pdf
  130. Cannabis zwischen problem und problematisierung.pdf
  131. Cardiac arrest following cannabis use- -Case report.pdf
  132. Central modulation of pain.pdf
  133. Cesamet PI 50 count.pdf
  134. Characterization-of-Medicinal-Properties-of-Cannabis-Sativa-L-Roots.pdf
  135. Characterization and localization of cannabinoid receptors in rat brain.pdf
  136. Characterization of Anandamide-Stimulated Cannabinoid Receptor Signaling in Human ULTR Myometrial Smooth Muscle Cells.pdf
  137. Charakterisierung naturfaserverstärkte Verbundwerkstoffe.Diss.Thomas Lampke2001.pdf
  138. Chemical Modification of Hemp Fibers by Silane Coupling Agents.pdf
  139. Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol2015 Hanlon JCEM.pdf
  140. Climate Change Impacts on Weeds.pdf
  141. Climbing Fiber-Evoked Endocannabinoid Signaling Heterosynaptically.pdf
  142. Clinical pharmacology of cannabinoids in early phase drug development.pdf
  143. Cognitive Function as an Emerging Treatment Target for Marijuana Addiction.pdf
  144. Cold resitance of hemp.pdf
  145. Combined antiproliferative effects of the aminoalkylindole and radiation in bresa cancer cells.pdf
  146. Common Genetic Contributions to Alcohol and Cannabis Use and Dependence Symptomatology.pdf
  147. Common genetic influences on the timing of first use for alcohol cigarettes and cannabis in young African-American women.pdf
  148. Comparing the Land Requirements Energy Savings and Greenhouse Gas Emissions eduction of Biobased Polymers and Bioenergy.pdf
  149. Composites from Northern Red Oak -Quercus robur- Leaves and Plant Oil-Based Resins.pdf
  150. Concerted Action of CB1 Cannabinoid Receptor and Deleted in Colorectal Cancer in Axon Guidance.pdf
  151. Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome wide association study of comorbid alcoholism and bipolar disorder.pdf
  152. Consommation de drogues et droits de l.enfant.pdf
  153. Constitutive Activity at the Cannabinoid CB1 Receptor Is Required for Behavioral Response.pdf
  154. Consumption of cannabis and cocaine-Correct mix for arterial occlusions.pdf
  155. Continued cannabis use and risk of incidence and persistence of psychotic symptoms 10 year follow-up cohort study.pdf
  156. Contrasting Effects of WIN 55212–2 on Motility of the Rat Bladder and Uterus.pdf
  157. Controlling Neural Function with Light.pdf
  158. Crop physiology of fibre hemp-Cannabis sativa L.pdf
  159. Cross-national comparison of adolescent drinking and cannabis use in the United States Canada and the Netherlands.pdf
  160. Cross-national differences in clinically significant cannabis problems epidemiologic evidence from cannabis-only smokers in the United States, Mexico, and Colombia.pdf
  161. Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain.pdf
  162. Crystallization and preliminary X-ray diffraction studies of polyketide synthase-1 PKS-1 from Cannabis sativa.pdf
  163. Crystallization of D1-tetrahydrocannabinolic acid THCA synthase from Cannabis sativa.pdf
  164. Cure kinetics of an epoxidized hemp oil based bioresin system.pdf
  165. Curing kinetics and effects of fibre of hemp-epoxy composites-2009.pdf
  166. D9-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory.pdf
  167. D9-Tetrahydrocannabinol 11-Hydroxy-THC and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC.pdf
  168. Das therapeutische Potenzial von Cannabis und Cannabinoiden.pdf
  169. Decrease in adolescent cannabis use from 2002 to 2006 and links to evenings out with friends in 31 European and North America countries and regions.pdf
  170. Deforestacion Cannabis Cultivacio and Schwingmoor Fformation at Cors Llyn Central Wales.pdf
  171. Denial of Petition To Initiate Proceedings To Reschedule Marijuana 8.July.2011 CRC Petition DEA Answer.pdf
  172. Detection of Marijuana Use by Oral Fluid and Urine Analysis Following Single-Dose Administration of Smoked and Oral Marijuana.pdf
  173. Development of Cannabinoid 1 Receptor Protein and Messenger RNA in Monkey Dorsolateral Prefrontal Cortex.pdf
  174. Differences in Regional Blood Volume During a 28-Day Period of Abstinence in Chronic Cannabis Smokers.pdf
  175. Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic-associative and sensorimotor cortical areas.pdf
  176. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use.pdf
  177. Direct modulation of the outer mitochondrial by cannabidiol voltage-dependent anion channel 1.pdf
  178. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry.pdf
  179. Disposition of Cannabinoids in Oral Fluid after Controlled Around-the-Clock Oral THC Administration.pdf
  180. Disrupted reflection impulsivity in cannabis users but not current or former ecstasy users.pdf
  181. Dissociable Systems for Gain- and Loss-Related Value Predictions and Errors of Prediction in the Human Brain.pdf
  182. Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization.pdf
  183. Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice.pdf
  184. Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission.pdf
  185. Diuretic effects of cannabinoids.pdf
  186. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of D9-tetrahydrocannabinol.pdf
  187. Do cannabinoids reduce brain power..interrogation..pdf
  188. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis- A double-blind, randomized- placebo-controlled study on 160 patients-Mult Scler-2004-Wade.pdf
  189. Domestic Cannabis Cultivation Assessment 2007.pdf
  190. Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions.pdf
  191. Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex.pdf
  192. Dosing Medical Marijuana Rational Guidelines on Trial in Washington State.pdf
  193. Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements.pdf
  194. Dronabinol for the Treatment of Cannabis Dependence A Randomized Double-Blind Placebo-Controlled Trial.pdf
  195. Drug-Induced Psychosis- How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light.pdf
  196. Drugs and driving in new zeland an appoach thc culpability 2006.pdf
  197. ERK-Dependent Modulation of Cerebellar Synaptic Plasticityafter Chronic Delta9 Tetrahydrocannabinol Exposure.pdf
  198. Effect of nitrogen on tetrahydrocannabinol content in Cannabis sativa L leaves at different positions.pdf
  199. Effects of Cannabis Use on Human Brain Structure in Psychosis- A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies.pdf
  200. Effects of Chronic Active Cannabis Use on Visuomotor Integration, in Relation to Brain Activation and Cortisol Levels.pdf
  201. Effects of Chronic Heavy Cannabis Use on Executive Functions.pdf
  202. Effects of Research Setting on Observed Depressive Symptoms in Marijuana Users.pdf
  203. Effects of THC and Lofexidine in a Human Laboratory Model of Marijuana Withdrawal and Relapse.pdf
  204. Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain-J Neurophysiol-2006-Liu.pdf
  205. Effects of cannabis on cognitive function in patients with multiple sclerosis.pdf
  206. Effects of haloperidol on the behavioral subjective cognitive motor and neuroendocrine effects of D9-tetrahydrocannabinol in humans.pdf
  207. Effekte von cannabis und ecstasy auf die neurokognitive hirnfunktion beim menschen 2010.pdf
  208. Einfluss des Endocannabinoidrezeptorsystems auf die Leberfibrose im Thioacetamid-Ethanol-Modell der Maus.pdf
  209. Endocannabinoid Signaling Dynamics Probed with Optical Tools.pdf
  210. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.pdf
  211. Endocannabinoides.Un nuevo sistema de comunicacion en el cerebro.Guzman Galve RANF 2008.pdf
  212. Endocannabinoids - The Brain and Bodys Marijuana and Beyond.pdf
  213. Endocannabinoids Link Feeding State and Auditory Perception-Related Gene Expression.pdf
  214. Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity.pdf
  215. Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission.pdf
  216. Endocannabinoids and the Brain Immune System. New Neurones at the Horizon.pdf
  217. Endocannabinoids and the regulation of body fat- the smoke is clearing.pdf
  218. Endocannabinoids in liver disease.pdf
  219. Endocannabinoids in nervous system health and disease-The big picture in a nutshell.pdf
  220. Endocannabinoids in the Retina From Marijuana to Neuroprotection.pdf
  221. Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction.pdf
  222. Enzymatic Machinery for Endocannabinoid Biosynthesis Associated with Calcium Stores in Glutamatergic Axon Terminals.pdf
  223. Erstellung einer genetischen Karte an Hanf mit molekularen Markern.pdf
  224. Estudio del cultivo de Cannabis Sativa en el Rif marroquí y sus consecuencias socioeconómicas para la Región.pdf
  225. Evaluating the effect of Cannabis sativa seed extraction on memory.pdf
  226. Evaluation of Binding in a Transfected Cell Line Expressing a Peripheral Cannabinoid Receptor -CB2- Identification of Cannabinoid Receptor Subtype Selective Ligands1.pdf
  227. Evaluation of Prevalent Phytocannabinoids in the Acetic Acid Model of Visceral Nociception.pdf
  228. Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa.pdf
  229. Evaluation of the Effects of Sativex -THC BDS CBD BDS- on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis- AModel ofMultiple Sclerosis.pdf
  230. Evaluation of the cognitive functioning of individuals on methadone-2009.pdf
  231. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.pdf
  232. Evidence that the plant cannabinoid cannabigerol is a highly potent a2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.pdf
  233. Evidenzbasierte behandlung der cannabisabhaengigkeit daeb2005.pdf
  234. Excretion of D9-Tetrahydrocannabinol in Sweat.pdf
  235. Executive Dysfunction in Cocaine Addiction Evidence for Discordant Frontal Cingulate and Cerebellar Activity.pdf
  236. Exploiting Cannabinoid Induced Cytotoxic Autophagy to Drive Melanoma Cell Death.pdf
  237. Extended Urinary D9-Tetrahydrocannabinol Excretion in Chronic Cannabis Users Precludes Use as a Biomarker of New Drug Exposure.pdf
  238. Fatty acid amide hydrolase deficiency limits early pregnancy events.pdf
  239. Finding cannabinoids in hair does not prove cannabis consumiption.pdf
  240. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect Consumption of cannabis and cocaine correct mix for arterial occlusions.pdf
  241. Food Protein-Derived Bioactive Peptides Production Processing and Potential Health Benefits.pdf
  242. Food for thought- endocannabinoid modulation of lipogenesis.pdf
  243. From child maltreatment to adolescent cannabis abuse and dependence- A developmental cascade model.pdf
  244. Functional Interactions between Stress and the Endocannabinoid System.pdf
  245. Functional role of cannabinoid receptors in urinary bladder.pdf
  246. Funktionelle Aspekte des Kohlenhydratmetabolismus während der Mykorrhizierung von Tabak.pdf
  247. Gambling Severity Predicts Midbrain Response to Near-Miss Outcomes.pdf
  248. GeneMapper 4.0 Guide.pdf
  249. Genese der praehistorischen Archaeologie prom.pdf
  250. Genotypendifferenzierung und Erstellung von Kreuzungspopulationen bei Hampf.prom.pdf
  251. Genotypendifferenzierung und Erstellung von Kreuzungspopulationen bei Hanf-Cannabis sativa L.pdf
  252. Genotypendifferenzierung und Erstellung von Kreuzungspopulationen bei Hanf.pdf
  253. Graphs Cannabis herb global seizures 2000-2012.pdf
  254. Graphs Cannabis resin global seizures 2000-2010.pdf
  255. Harm reduction-the cannabis paradox.pdf
  256. Hempseed cake as a protein feed for ruminants.pdf
  257. High times for cannabis research.pdf
  258. Hippocampal Neurotoxicity of Delta9-Tetrahydrocannabinol.pdf
  259. History of Cannabis and Its Preparations in Saga Science and Sobriquet.pdf
  260. How hemp got high gb-2011-12-10-409.pdf
  261. How important are sex differences in cannabinoid action.pdf
  262. Human Cannabinoid Pharmacokinetics.pdf
  263. Identification of candidate genes affecting D9-tetrahydrocannabinol biosynthesis in Cannabis sativa.pdf
  264. Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides.pdf
  265. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R-plus-WIN55-coma.212.pdf
  266. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R.+.WIN55.212.pdf
  267. Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.pdf
  268. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users.pdf
  269. Implications of Plasma D9-Tetrahydrocannabinol 11-Hydroxy-THC and 11-nor-9-Carboxy-THC Concentrations in Chronic Cannabis Smokers.pdf
  270. InTech-Gas chromatography in forensic chemistry cannabinoids content in marijuana leaves cannabis sativa l from colombia.pdf
  271. In Vitro de Tejidos Vegetales.pdf
  272. In silicio expression analysis of PKS genes isolated from Cannabis sativa L.pdf
  273. In situ Hybridisierung an Cannabis sativa L-Chromosomen.pdf
  274. In situ Hybridisierung an Hanf Chromosomen.pdf
  275. Increased Blood Pressure Following Abrupt Cessation of Daily Cannabis Use.pdf
  276. Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide.pdf
  277. Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine.pdf
  278. Increased mortality- hypoactivity- and hypoalgesia in cannabinoid CB1 receptor knockout mice.pdf
  279. Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users.pdf
  280. Industrial Cannabis sativa L-a high-yielding energy crop.pdf
  281. Industrial Hemp as a Papermaking Raw Material.pdf
  282. Influence of Cannabis Use on Severity of Hepatitis C Disease.pdf
  283. Influence of fibre processing and treatments on hemp fibre-epoxy-PLA-Comp-2008.pdf
  284. Influence of the physico-mechanical properties of alkali-treated hemp fibre-2010.pdf
  285. Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1.pdf
  286. Inhibition of Recombinant Human T-type Calcium Channels by D9-Tetrahydrocannabinol and Cannabidiol.pdf
  287. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids.pdf
  288. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R-Methana-damide and JWH-015 Involvement of CB2.pdf
  289. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoi receptors.pdf
  290. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.pdf
  291. Interacción del delta-nueve-tetrahidrocannabinol con el sistema opioide central en roedores.pdf
  292. Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence.pdf
  293. Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase-Akt Signaling.pdf
  294. Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum A.pdf
  295. Isolierung von DNA.pdf
  296. Laboratory and Outdoor Assessment of UV Protection Offered by Flax and Hemp Fabrics Dyed with Natural Dyes.pdf
  297. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain.pdf
  298. Lifestyle behaviours of young adult survivors of childhood cancer.pdf
  299. Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry Analysis of 7-Ethylguanine in Human Liver DNA.pdf
  300. Localization and Mechanism of Action of Cannabinoid Receptors.pdf
  301. Localization of the Endocannabinoid-Degrading Enzyme Fatty Acid Amide Hydrolase.pdf
  302. Long-Lasting Increase of Alcohol Relapse by the Cannabinoid.pdf
  303. Los cannabinoides y el sistema endocannabinoide.pdf
  304. Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice.pdf
  306. MEDICINAL PLANTS OF THE WORLD Cannavbis sativa L.GetMmo.pdf
  307. MONOGRAFÍA CANNABIS.Julio Bobes-Amador Calafat.2000.pdf
  308. Marijuana Retail and wholesale prices and purity levels by drug region and country or territory - Prices CannabisType.pdf
  309. Marijuana and Pregnancy.pdf
  310. Marijuana and the Cannabinoids.pdf
  311. Marijuana based Drugs- Innovative Therapeutics or Designer Drugs of Abuse.pdf
  312. Marijuana craving in the brain.pdf
  313. Marijuana craving in the brain .pdf
  314. Mechanical performance-of industrial hemp fibre peinforced polylactide and unsaturated polyester composites-2009.pdf
  315. Mechanisms Underlying the Link between Cannabis Use and Prospective Memory.pdf
  316. Mechanisms of Cannabinoid Inhibition of GABAASynaptic Transmission in the Hippocampus.pdf
  317. Medica marijuana laws and-suicide.pdf
  318. Medical Marijuana Law Accidents and Alcohol 01.23.2012.v1.pdf
  319. Medical marijuana users in substance abuse treatment.pdf
  320. Medicinal Aplications of Delta-9 Tetrahydrocannabidol and Marijuana.pdf
  321. Memory Systems and the Addicted Brain.pdf
  322. Methamphetamine Causes Microglial Activation in the Brains of Human Abusers.pdf
  323. Micro-pulverized extraction pretreatment for highly sensitive analysis of THC in hair.pdf
  324. Microbial quality of hemp and flax from plants to thermal insulation.pdf
  325. Mini-Symposium Stress and Disease Is Being Female a Predisposing Factor.pdf
  326. Mitochondrial CB1 receptors regulate neuronal energy metabolism 2012.pdf
  327. Modeling the genetic and environmental association between peer group deviance and cannabis use in male twins.pdf
  328. Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol an fMRI Study.pdf
  329. Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol an fMRI Study b.pdf
  330. Molecular mechanisms underlying the effects of cannabinoids in the brain.pdf
  331. Molecular targets for cannabidiol and its synthetic analogues- effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.pdf
  332. Molekulargenetische Diversitaet einer monoezischen und einer dioezischen Hanfsorte und Analyse des Fasergehaltes von verschiedenen Hanfformen.pdf
  333. More evidence cannabis can help in neuropathic pain.pdf
  334. Multpiple Sclerosis and Extract of Cannabis- Results of the MUSEC trial-2012-Zajicek.pdf
  335. Neural Encoding of Psychomotor Activation in the Nucleus Accumbens Core.pdf
  336. Neurobiological effects of early life cannabis exposure in relation to the gateway hypothesis.pdf
  337. Neuropeptide S Reinstates Cocaine-Seeking Behavior and Increases Locomotor Activity.pdf
  338. Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication.pdf
  339. Neuroprotection by Tetra 9 Tetrahydrocannabinol, the Main Active Compound in Marijuana.pdf
  340. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.pdf
  341. New fossil evidence for the past cultivation and processing of Hemp in Eastern England.pdf
  342. Next-generation biopolymers.Advanced functionality and improved sustainability.pdf
  343. Nicotinic a7 Receptors as a New Target for Treatment of Cannabis Abuse.pdf
  344. Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity.pdf
  345. Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration.pdf
  346. Nuevas aprtaciones al estudio de los Cannabinoides- 1 Efectos vasculares- 2 Caracterizacio de nuevos compuestos.pdf
  347. Numerical Taxonomic Analysis of Cannabis with Special Reference to Species Delimitation1.Small1976.pdf
  348. Opposite Effects of D9 Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology.pdf
  349. Oral fluid cannabinoids in chronic- daily Cannabis smokers during sustained- monitored abstinence.pdf
  350. Organelle DNA haplotypes reflect crop-use characteristics and geographic origins of Cannabis sativa Haplotypes1.pdf
  351. Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases- Physiological and Pharmacological Implications.pdf
  352. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.pdf
  353. Performance of hemp-fibre reinforced polypropylene composite materials-2007.pdf
  354. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.pdf
  355. Personality- Psychopathology- Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca- A Longitudinal Study.pdf
  356. Pharmacologic Treatment of First-Episode Schizophrenia A Review of the Literature.pdf
  357. Pharmacological Evaluation of the Natural Constituent of Cannabis Sativa Cannabichromene and its Modulation by D9 Tetrahydrocannabinol.pdf
  358. Pharmacological Treatment of Cannabis Dependence.pdf
  359. Pharmacological interventions in the treatment of the acute effects of cannabis a systematic review of literature.pdf
  360. Pharmacology of Cannabinoids.pdf
  361. Pharmakokinetik und Metabolismus von THC saeure-A im Menschen von Wohlfarth 2012.pdf
  362. Physikalische Fasereigenschaften von Hanf-Cannabis sativa L- in Abhaengigkeit von Bestandesentwicklung- Strohmanagement- Roeste und Faseraufschluss.pdf
  363. Physikalische Fasereigenschaften von Hanf.pdf
  364. Physiologische Grundlagen der Akkumulation von Schwermetallionen beim Faserhanf und das Nutzungspotential bei der Phytoremediation.pdf
  365. Physiologische Grundlagen der Akkumulation von Schwermetallionen beim Faserhanf.pdf
  366. Physiologische Grundlagen der Akkumulation von Schwermetallionen beim Faserhanf -Cannabis sativa L- und das Nutzungspotential bei der Phytoremediation.pdf
  367. Phytochemical and genetic analyses of ancient cannabis from Central Asia.pdf
  368. Phytotherapie in der Augenheilkunde.pdf
  369. Plant oil renewable resources as green alternatives in polymer science.pdf
  370. Polyketide synthases in Cannabis sativa L-ThesisFloresSanchez.pdf
  371. Polyolefin Composites with Natural Fibers and Wood-Modification of the Fiber-Filler–Matrix Interaction.pdf
  372. Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons.pdf
  373. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.pdf
  374. Prenatal Stress and Peripubertal Stimulation of the Endocannabinoid System Differentially Regulate Emotional Responses and Brain Metabolism in Mice.pdf
  375. Prenatal and Adolescent Exposure to Tobacco Smoke Modulates the Development of White Matter Microstructure.pdf
  376. Presynaptic Homeostatic Plasticity Rescues.pdf
  377. Prevention of Cannabinoid Withdrawal Syndrome by Lithium.pdf
  378. Processing-property relationships of hemp fibre-2006.pdf
  379. Processing of hemp fibre using enzyme-fungal treatment for composites 2009.pdf
  380. Prospects for cannabinoid therapies in basal ganglia disorders.pdf
  381. Prostaglandin E2 Acts on EP1 Receptor and Amplifies Both Dopamine D1 and D2 Receptor Signaling in the Striatum.pdf
  382. Prüfung von Hanföl hinsichtlich seiner Eignung als Kraftstoff für Pflanzenöltaugliche Motoren.2007 08-03 hanfoel als kraftstoff nova-tfz.pdf
  383. Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT-3A- receptors through a recept.pdf
  385. Reaching out towards cannabis approach-bias in heavy cannabis users predicts changes in cannabis use.pdf
  386. Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users.pdf
  387. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein .pdf
  388. Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus.pdf
  389. Rehashing endocannabinoid antagonists-can we selectively target the periphery to safely treat obesity and type 2 diabetes.interogation.pdf
  390. Rehashing endocannabinoid antagonists. can we selectively target the periphery to safely treat obesity and type 2 diabetes. interogation .pdf
  391. Relationship of Cannabinoid CB1 Receptor and Cholecystokinin Immunoreactivity in Monkey Dorsolateral Prefrontal Cortex.pdf
  392. Rescue of Locomotor Impairment in Dopamine D2 Receptor-Deficient.pdf
  393. Results in Neuropathic Pain Behavior That Is by Cannabinoids.pdf
  394. Retrograde Endocannabinoid Signaling in a Postsynaptic Neuron Synapti.pdf
  395. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers.pdf
  396. Rimonabant 2005-01-041.pdf
  397. Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes.pdf
  398. Role of the endocannabinoid system in the regulation of biological processes of human skin derived cells-Dobrosi Nora Study in Hungarian.pdf
  399. SATIVEX2011.pdf
  400. Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection.pdf
  401. Self-administration of cocaine cannabis and heroin in the human laboratory-benefits and pitfalls.pdf
  402. Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor Independent Mechanism.pdf
  403. Sequenced anaerobic-aerobic treatment of hemp pulping wastewaters.pdf
  404. Serotonin. the Prefrontal Cortex, and the Antidepressant Like Effect of Cannabinoids.pdf
  405. Severe multisystem dysfunction in a case of high level exposure to smoked cannabis.pdf
  406. Short scales to assess cannabis-related problems a review of psychometric properties.pdf
  407. Simultaneous cannabis and tobacco use and cannabis-related outcomes in young women.pdf
  408. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.pdf
  409. Sleep Loss Boosts Hunger and Unhealthy Food Choices.pdf
  410. Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol.pdf
  411. Smoked Medicinal Cannabis for Neuropathic Pain in HIV A Randomized Crossover Clinical Trial.pdf
  412. Smoked cannabis for spasticity in multiple sclerosis- a randomized, placebo-controlled trial.pdf
  413. Smoking tobacco along with marijuana increases symptoms of cannabis dependence.pdf
  414. Spontaneous Withdrawal from the Triazoloben odiazepine.pdf
  415. Standardized cannabis in multiple sclerosis-Case report.pdf
  416. Structure determination and absolute configuration of cannabichromanone derivatives from high potency Cannabis sativa.pdf
  417. Substance abuse and risk of labour market exclusion from youth to adulthood.pdf
  418. Substitutionsmedizin in Deutschland Juni 2012-1.pdf
  419. Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist.pdf
  420. Survey of Australians using cannabis for medical purposes.pdf
  421. Sustainable Production of Cannabinoids with Supercritical Carbon Dioxide Technologies HPerrotin-Brunel-PhD.pdf
  422. Systems Biology based studies on anti-inflammatory compounds-Thesis Kitty Verhoeckx.pdf
  424. TRPV2 Is Activated by Cannabidiol and Mediates CGRP Release in Cultured Rat Dorsal Root Ganglion Neurons.pdf
  425. Talcum induced pneumoconiosis following inhalation of adulterated marijuana a case report.pdf
  426. Taming THC- potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.pdf
  427. Taming THC potential cannabis synergy and phytocannabinoid-terpenoid entourage effects-Russo.pdf
  428. Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease- Evidence from an Experimental Murine Model.pdf
  429. The Battle of the LTDs in the Cerebellum.pdf
  430. The Association between Cannabinoid Receptor 1 Gene CNR1 and Cannabis Dependence Symptoms in Adolescents and Young Adults.pdf
  431. The CB1 Cannabinoid Receptor Can Sequester G-Proteins.pdf
  432. The CB1 Cannabinoid Receptor Is the Major Cannabinoid Receptor at Excitatory Presynapti.pdf
  433. The Check Your Cannabis Screener A New Online Personalized Feedback Tool.pdf
  434. The Endocannabinoid 2Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons.pdf
  435. The Endocannabinoid Anandamide Metabolism & Neuroprotection.pdf
  436. The Endocannabinoid System and Pain.pdf
  437. The Inhibition of DNA Synthesis by Cannabinoids.pdf
  438. The Institute of Bast Crops-Hemp research and growin in Ukraine.pdf
  439. The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use.pdf
  440. The Medical Use of Cannabis Among the Greeks and Romans.pdf
  441. The New Generation of Cannabinoid Designer Drugs.pdf
  442. The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice.pdf
  443. The Therapeutic Potential of Cannabis and Cannabinoids.pdf
  444. The cannabinoid agonist WIN55.212-2 increases intracellular calcium via CB1 receptor coupling to Gq.11 G proteins.pdf
  445. The cannabis use problems identificacation test cupid-2007.pdf
  446. The carbon footprint of indoor Cannabis production sep2012.pdf
  447. The draft genome and transcriptome of Cannabis sativa-2011 gb-2011-12-10-r102.pdf
  448. The effects of cannabinoids on serum cortisol and prolactin in humans.pdf
  449. The endocannabinoid system.a key modulator of emotions and cognition.pdf
  450. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.pdf
  451. The endogenous cannabinoid system protects against colonic inflammation.pdf
  452. The impact of cannabis on your lungs-BLF report 202012.pdf
  453. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis..pdf
  454. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.pdf
  455. The potential of industrial hemp -Cannabis sativa L- for biogas production- -Emma Kreuger thesis.pdf
  456. The profile of immune modulation by cannabidiol -CBD- involves deregulation of nuclear factor of activated T cells -NFAT- Biochem Pharmacol.pdf
  457. The role of cannabinoids in prostate cancer Basic science perspective and potential clinical applications.pdf
  458. The therapeutic potential of cannabis.edit1183.pdf
  459. The therapeutic potential of cannabis.pdf
  460. The therapeutic potential of cannabis P 5258 13420 1.pdf
  461. Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis.pdf
  462. Toxicologia del cannabis bacell20169-174.pdf
  463. Transient Receptor Potential Vanilloid Subtype 1.pdf
  464. Two Brain Sites for Cannabinoid Rewar.pdf
  466. US Patent 6630507 Cannabinoids as antioxidants and neuroprotectants .pdf
  467. Ultrastructural Localization of the CB1 Cannabinoid Receptor.pdf
  468. Untersuchungen zur entzuendungshemmenden Wirkung von Cannabis sativa L- Extrakten im Modell der Gewebekulturen- -Nadig Alexandra.pdf
  469. Urinary Elimination of 11-Nor-9-Carboxy-D9-tetrahydrocannnabinol in Cannabis Users During Continuously Monitored Abstinence.pdf
  470. Validation of an Enzyme Immunoassay for Detection and Semiquantification of Cannabinoids in Oral Fluid.pdf
  471. Vegetation of Kilimanjaro hidden endemics and missing bamboo.pdf
  472. Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis.pdf
  473. Whole plant cannabis extracts in the treatment of spasticity n multiple sclerosis-A systematic review.pdf
  474. World Drug Report 2011 ebook.pdf
  475. World Drug Report 2012 web small.pdf
  476. endocannabinoid signalling and the deteriorating brain.pdf
  477. seminario .jpg

© DEMETER_MiMo2011-2020